Sellas Life Sciences
SLS----
Sellas Life Sciences (SLS)
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indicatio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Sellas Life Sciences Analyst Rating
View MoreForecast & Rating
Jul 8, 2026Price forecast
$27.50119.65%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 1 day ago, 04:18 AM
Global Expansion Clashes with Domestic Realities: 10 Companies Navigating the 2026 Macro Crosscurrents
- Simplywall · Jul 17 at 12:05 PM
Does SELLAS (SLS) Using a $154.6M Shelf Refine Its Path to Self-Funded Oncology Growth?
- benzinga_article · Jul 8 at 10:09 AM
SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall
- rttnews · Jul 3 at 12:19 AM
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
- Options Flow · Jul 1 at 11:25 PM
Trending | SLS Plummets 10% on Wednesday, Some Put options Surges 77%
- benzinga_article · Jun 30 at 08:39 AM
SELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move?
